24 results on '"Kennedy, Sarah J."'
Search Results
2. Colorimetric assays for the rapid and high-throughput screening of antimicrobial peptide activity against diverse bacterial pathogens
3. Draft genome sequence of a highly proteolytic Staphylococcus aureus USA300 isolate from human urine
4. Staphylococcus aureus SigS Induces Expression of a Regulatory Protein Pair That Modulates Its mRNA Stability
5. Data from Baseline Vascular Endothelial Growth Factor Concentration as a Potential Predictive Marker of Benefit from Vandetanib in Non–Small Cell Lung Cancer
6. Supplementary Data from Baseline Vascular Endothelial Growth Factor Concentration as a Potential Predictive Marker of Benefit from Vandetanib in Non–Small Cell Lung Cancer
7. Tongalides, Halogenated Butenolides from an Antarctic Delisea sp. Rhodophyte
8. Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial
9. Phenogenomic characterization of a newly domesticated and novel species from the genus Verrucosispora
10. Tongalides, Halogenated Butenolides from an Antarctic sp. Rhodophyte.
11. The Effects of a Functional Food Breakfast on Gluco-Regulation, Cognitive Performance, Mood, and Satiety in Adults
12. Genetic divergence and evidence of human‐mediated translocation of two‐fingered sloths (Choloepus hoffmanni) in Costa Rica
13. Draft Genome Sequence of Verrucosispora sp. Strain CWR15, Isolated from a Gulf of Mexico Sponge
14. A Phase I Study of Vandetanib in Combination with Vinorelbine/Cisplatin or Gemcitabine/Cisplatin as First-Line Treatment for Advanced Non-small Cell Lung Cancer
15. Cheap labor: myosin fiber type expression and enzyme activity in the forelimb musculature of sloths (Pilosa: Xenarthra)
16. Vandetanib Versus Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: Results From a Two-Part, Double-Blind, Randomized Phase II Study
17. Baseline Vascular Endothelial Growth Factor Concentration as a Potential Predictive Marker of Benefit from Vandetanib in Non–Small Cell Lung Cancer
18. Randomized, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer
19. PD3-3-4: Vandetanib in advanced NSCLC: an ongoing clinical evaluation program
20. Tongalides, Halogenated Butenolides from an Antarctic Deliseasp. Rhodophyte
21. Vandetanib in advanced NSCLC: an ongoing clinical evaluation program.
22. Culture-dependent identification of rare marine sediment bacteria from the Gulf of Mexico and Antarctica.
23. Colorimetric assays for the rapid and high-throughput screening of antimicrobial peptide activity against diverse bacterial pathogens.
24. Genetic divergence and evidence of human-mediated translocation of two-fingered sloths (C holoepus hoffmanni ) in Costa Rica.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.